$7.290
-0.060 (-0.82%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ATAI Prediction & Forecast by Similar Chart Analysis
Alphio's ATAI stock price prediction model matches the current AtaiBeckley Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.34 (+0.67%). The 1-week path is $7.15 (-1.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy AtaiBeckley Inc Stock?
ATAI Life Sciences NV is not a good buy right now, as the current price of $7.29 is above the downgraded analyst price targets of $7.50 and $8. The stock has experienced a significant decline in analyst ratings due to the pending acquisition by Eli Lilly, which offers a cash payment of $6.75 per share plus contingent payments. Furthermore, the RSI is at 40.989, indicating a lack of momentum for a potential upward move, and the recent 5-day change is down by 1.22%.
ATAI stock price ended at $7.29 on Friday, after losing -0.82%
AtaiBeckley Inc (ATAI) last closed at $7.29, losing -0.82%. These facts feed the 1-day and 1-week ATAI price prediction above.
Forecast Drivers
AtaiBeckley Inc (ATAI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ATAI, ranked by similarity.
Seasonality analysis for ATAI
Historically the probability of a positive August return for ATAI is 65.08%. February offers the highest probability of a positive month at 79.31%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.